Additionally, retatrutide markedly improved lipid profiles in people with T2D or obesity, reducing total cholesterol (~ 1518%), LDL (~ 1222%), and triglycerides (~ 3540%)surpassing dulaglutide 1.5 mg
Learn about other Q&A about proteomics technology
Animal models and observational human data on individual components suggest improvements in lean-to-fat ratio, with retained nitrogen balance during caloric restriction
Peroxisomal HPR1 plays a major role in reducing hydroxypyruvate with NADH as the co-factor, whereas HPR2 and HPR3 in the cytosol have low activities and higher affinities for NADPH 16,17,18,19
There are alternatives like lifestyle changes and evidence-backed supplements that can also support hormonal balance
A full comparison of the cohorts baseline demographics, comorbidities, medications, and lab values between the two cohorts before and after PSM is highlighted in the Supplementary Materials